Introduction
Anxiety disorders are common in patients with epilepsy 1 and adversely affect patients' quality of life. 2 Possible risk factors for anxiety in epilepsy may include seizure frequency, perceived stigma, and late onset, treatment refractory and focal epilepsies. 3 Anxiety disorders occur in approximately 20% of patients with focal epilepsies. 4 A recent study on the prevalence of anxiety disorders in patients with temporal lobe epilepsy (TLE), the most common type of focal epilepsy, reported a rate of 18%. 5 Frontal lobe epilepsy (FLE), another common type of focal epilepsy, takes up about 15% of all patients with pharmaco-resistant epilepsies. FLE is associated with psychopathology including executive dysfunctions, cognitive impairment, hyperactivity, obsession, and addictive behavior. 6 It is yet unknown if FLE is associated with anxiety symptoms. A comparison of 67 TLE patients with 64 non-TLE patients (mostly FLE) yielded no difference in the anxiety state or trait scores or the frequency of anxiety disorders. 7 Similarly, the personality profile of 58 FLE and 39 TLE patients did not reveal differences in anxiety-related traits. 8 The aim of this study was to examine if anxiety symptoms were more common in patients with FLE in comparison to those with generalized epilepsy (GE). We hypothesized that the level of anxiety symptoms would be higher in patients with FLE.
Methods
Patients were enrolled in the study between March and June 2007. The details of the methodology have been published elsewhere. 9 Briefly, consecutively assessed patients when attending the neurology outpatient clinics at Prince of Wales Hospital were recruited. Inclusion criteria were age =/>18 years, diagnosed with epilepsy and being literate in Chinese language. Each patient was interviewed by a trained epileptologist who also reviewed the medical charts to collect demographic data (age, sex, and marital status), history of previous psychiatric illness and current medical information. Past psychiatric history was recorded. 15 for the HADSA/HADSD and HARS, respectively.
The scales were self administered by the patients. The HADSA and HADSD were originally developed as a self-rating instrument. 14 The anxiety scores and the demographic and clinical characteristics between the FLE and GE groups were compared using the t-test and Mann-Whitney U-test. Categorical data (sex, marital status, etiology, current AED treatment) were compared using chi square test. Pearson's correlation and stepwise linear multiple regression analysis were used to explore the association of the anxiety and depression scores with the epilepsy-related variables (age at onset, duration of epilepsy, seizure frequency, and number of current AEDs). All statistical tests were performed using SPSS for Windows (Release 16.0; SPSS Inc., Chicago, IL, USA). The significance level of p value was set at 0.05.
The study protocol was approved by the Clinical Research Ethics Committee of the Chinese University of Hong Kong. All participants signed a consent form.
Results
A total of 247 patients completed the questionnaires, of whom 40 and 78 were classified as having FLE and GE, respectively and were included in the analysis. Of the patients with FLE, 34 had an MRI, which demonstrated abnormality in left, right and bilateral frontal lobe in 6, 14, and 2 cases, respectively. No differences in age, sex, marital status, age of onset and duration of epilepsy were found between the two groups. GE patients were more likely to have idiopathic etiology, less frequent seizure attacks, and lower number of current AEDs [ Table 1 ].
In the GE group, 14 (17.9%), 22 (28.2%) and 22 (28.2%) patients scored above the cut-off points of the HDRS, HADSA and HADSD, respectively; the corresponding figures in the FLE group were 10 (25.0%), 16 (40.7%) and 14 (35.0%).
Compared to the GE group, the FLE group had a significantly higher HARS (10.9 AE 8.7 vs. 7.9 AE 6.8, p = 0.039) and HADS total scores (13.0 AE 7.3 vs. 10.3 AE 6.4, p = 0.042). There was also a trend that the FLE group had a higher mean HADSD scores (6.6 AE 4.2 vs. 5.1 AE 3.5, p = 0.050).
The HARS, HADSA, HADSD and HADS total scores were all highly correlated with each other; the correlations ranged from 0.468 to 0.885 (p < 0.001). Significant correlations were also found between the anxiety and depression measures and the epilepsyrelated variables, particularly with the seizure frequency and the number of current AEDs [ Table 2 ].
Discussion
To the best of our knowledge, it was the first study that compared anxiety symptoms in patients with FLE and GE. FLE was associated with more anxiety symptoms.
The mean HADSA scores of our patients ranged from 5.2 to 6.5, which were considerably higher than the figure of 3.4 reported in a cohort of five thousand Chinese adults in Hong Kong. 17 Similarly, the mean depressive HADSD score of the subjects (5.1-6.6) were also higher than the figure of 3.7 reported in the Hong Kong population. 17 In this study, 22-41% of patients had significant anxiety symptoms measured by the HADSA. These figures are somewhat higher than the 20.5% reported in a sample of 515 patients with epilepsy. 18 Another study using the HAMA, reported a figure of 39% in a sample of 196 patients with epilepsy, 19 a rate similar to our results. Our findings are in line with the majority of the literature; the frequency of anxiety disorders was reported between 15% and 25%. 3 Our results also showed that the seizure frequency and number of AEDs were associated with anxiety and depressive symptoms, a finding consistent with the rest of the literature.
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The prevalence of past psychiatric illness was very low in our sample, much lower than the figures reported in the literature. 20, 21 The most likely explanation for this discrepancy is the underrecognition of psychiatric disorders by the treating physicians. 22, 23 Epileptic activity in certain areas of the brain directly causes paroxysmal anxiety, usually in the form of panic attacks. This led to a theory of a common pathophysiological mechanism for anxiety attacks and epilepsy, located mainly in the amygdala. 24 It is worth noting that ictal anxiety is also associated with seizures arising in the frontal lobe, namely the anterior cingulate or orbito-frontal cortex. 25 It has been hypothesized that the anterior cingulate regulate the activity in the amygdala and this regulatory function is abnormal in patients with anxiety. 26 A recent functional MRI (fMRI) study found a reduced anterior cingulate activation in patients with generalized anxiety disorder. 27 Another fMRI study reported that higher level of pretreatment anterior cingulate cortex activity was associated with greater reductions in anxiety following treatment with the antidepressant venlafaxine. 28 Similarly, neurocircuitry models of anxiety disorders have primarily focused on amygdalo-orbitofrontal circuit. The amygdala is implicated in generating fear responses, whereas the orbitofrontal region is linked to fear extinction. 29 Reduced orbitofrontal cortex thickness has been reported in patients with anxiety traits 30 and decreased functional connectivity between the orbitofrontal lobe and amygdala was found in patients with social anxiety disorder. 31 In terms of neurochemistry, pathological gamma-aminobutyric acid (GABA) serotonin function is also shared by epilepsy and anxiety disorders. The GABAergic antiepileptic drugs, pregabalin, barbiturates and benzodiazepines have both antiepileptic and anxiolytic properties. In a magnetic resonance spectroscopy study, prefrontal GABA is reduced by approximately 18% in experimentally induced, acute psychological stress relative to the safe condition. 32 There is also a negative correlation between frontal GABA level and neuroticism in healthy volunteers. 33 Altered serotonin receptor binding has been observed in patients with epilepsy [34] [35] [36] and panic disorder. 37 A PET study revealed a negative correlation between serotonin 1A binding and anxiety in the dorsolateral prefrontal and anterior cingulate cortex in healthy subjects. 38 In conclusion, several lines of evidence suggest that certain types of epilepsy and the spectrum of anxiety disorders share common pathophysiology and clinical features. The potential overlap of neurobiological and clinical aspects of these two disorders could be an important beacon for future research. The present study has the following main limitations. The sample size was relatively small. In addition, the DSM-IV diagnoses for specific anxiety disorders were not assessed by a standardized clinical interview; however, the scales used to measure anxiety are validated and commonly employed in epileptology. 39 Finally, due to its cross-sectional design, the study could not establish any causal relationship between psychopathology and FLE and GE. In summary, anxiety symptoms are more common in patients with FLE in comparison to those with GE. Further studies are warranted to clarify the relationship between anxiety and FLE, with the potential of devising more effective treatments for this comorbidity.
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